← All advisory

Business case · Aviation · Client: European asset manager

Rolls-Royce: the return to narrowbody propulsion

How likely is Rolls-Royce to re-enter the narrowbody engine market, and how does UltraFan compare with CFM RISE and the Pratt & Whitney GTF?

£2.5bn
UK government framework
€64m
EU Clean Aviation grant
15:1
UltraFan 30 bypass ratio
2028
Demonstrator ground test

The client and the question

A European asset manager invested in Rolls-Royce asked Northern Lights to assess one of the most consequential questions for the company’s long-term value: a return to the narrowbody engine market, where most future engine flight hours will be generated.

Will Rolls-Royce re-enter narrowbody propulsion, alone or with risk-sharing partners, and how competitive would UltraFan be against CFM RISE and the Pratt & Whitney GTF?

Context

Rolls-Royce left the narrowbody market when it exited its stake in the V2500 programme, focusing on widebody engines. The next generation of single-aisle aircraft, expected in the late 2030s, reopens the question.

Its UltraFan demonstrator has validated a scalable geared architecture. CFM is developing the RISE open-fan programme, while Pratt & Whitney continues to evolve its geared turbofan. Each architecture comes with different trade-offs in efficiency, noise, installation and maturity.

The next narrowbody engine decision will shape engine makers’ cash flows for fifty years.

Key questions

  1. Strategic intent. What would justify the investment and risk of a return to narrowbody engines?
  2. Partnering. Which risk-sharing structures and partners would make an entry credible?
  3. Technology. How does UltraFan compare with open-fan and geared turbofan alternatives on efficiency, maturity and installation?

Our approach

We combined an operator’s view of engine programme economics with a structured comparison of competing architectures.

  1. Programme economics. A model of investment, risk sharing and aftermarket returns for a new narrowbody engine.
  2. Architecture comparison. Side-by-side assessment of UltraFan, open fan and geared turbofan on fuel burn, noise, weight, integration and readiness.
  3. Entry scenarios. Probability-weighted scenarios for a solo entry, a partnership and no entry, with their implications for value.

Key insights

  1. The prize is the aftermarket.
    Narrowbody engines generate the majority of future flight hours and service revenue. Staying out caps Rolls-Royce’s long-term growth, but entering requires a decade of investment before returns, a trade-off investors must price explicitly.
  2. Partnering is the most likely route.
    Given the scale of investment and the strength of incumbent positions, a risk-sharing structure with industrial partners is more plausible than a solo entry, and would shape how much of the value Rolls-Royce captures.
  3. Architecture choice will follow the airframer.
    The decisive factor will be how the aircraft manufacturers design the next single-aisle. Open fan offers the largest efficiency gain but harder integration, while ducted geared designs are easier to install. UltraFan’s scalability keeps Rolls-Royce in the conversation.

Outcome

  1. A scenario-based valuation view.
    The client received probability-weighted scenarios for a narrowbody return and their impact on long-term cash flows.
  2. A technology scorecard.
    A clear comparison of competing architectures helped the portfolio team interpret announcements from engine and aircraft makers.
  3. Signposts to monitor.
    We defined the milestones that would indicate a move: partner announcements, airframer requirements and demonstrator results.

For discussion

  1. Should a widebody leader accept being absent from the largest engine market?
  2. What makes a risk-sharing partnership attractive to both the lead engine maker and its partners?
  3. Who decides the architecture of the next single-aisle engine, the engine makers or the aircraft manufacturers?

Based on public information and Northern Lights analysis. Client identity and engagement details are confidential.